A Growing Number Of People Suffer From So-called Resistant Hypertension, That Is To Say, High Blood Pressure That Does Not Respond To Treatment. This Disorder Is Of Great Current Interest And Importance For Public Health, Being A Common Clinical Problem Faced By Both Primary Care Clinicians And Specialists. Furthermore, As Older Age And Obesity Are Among The Strongest Risk Factors For Uncontrolled Hypertension, The Incidence Of Resistant Hypertension Will Likely Increase As The Population Becomes More Elderly And Heavier. While The Prognosis Of Resistant Hypertension Is Unknown, Cardiovascular Risk Is Undoubtedly Increased Since Patients Often Have A History Of Long-standing, Severe Hypertension Complicated By Multiple Other Cardiovascular Risk Factors. This Volume, Compiled By A Panel Of World-renowned Experts, Offers A Comprehensive Exploration Of Resistant Hypertension, Covering Epidemiology, Complex Diagnostic Aspects, And The Therapeutic Options Currently Available, With Due Attention To Overall Treatment Strategies. New Therapeutic Agents And Procedures, Such As Renal Denervation And Baroreceptor Stimulation, Are Also Described. In Addition, The Book Addresses The Economic Aspects Of Resistant Hypertension And The Role Of The Different Professional Figures, From Gps To Hypertension Specialists, In Dealing With It. Resistant Hypertension: Definition, Prevalence And Cardiovascular Risk -- Resistant Hypertension: Neurohumoral Aspects -- Metabolic Alterations -- Cardiac And Vascular Alterations In Resistant Hypertension -- The Pathophysiology Of The Kidney In Resistant Hypertension -- False Vs. True Resistant Hypertension -- Causes Of Resistant Hypertension -- 24-hour Ambulatory Bp Monitoring And Home Bp Measurements In Resistant Hypertension -- Factors Predicting Blood Pressure Response To Treatment -- Treatment Of Resistant Hypertension: Which Additional Antihypertensive Drugs? -- The Role Of Renal Denervation -- The Role Of Carotid Baroreceptor Stimulation -- Pathophysiology: Metabolic Alterations And Risk Factors -- Follow-up Of Patients With Resistant Hypertension -- Resistant Hypertension: Cost-benefit Considerations -- Involvement Of Health Professionals From The General Practitioner To The Hypertension Specialist And The Hypertension Center. Giuseppe Mancia, Editor. Includes Index. Mode Of Access: World Wide Web.

lgrsnf/A:\compressed\10.1007%2F978-88-470-5415-8.pdf

nexusstc/Resistant Hypertension: Epidemiology, Pathophysiology, Diagnosis and Treatment/03c144fcbb8d71f521d3a6a61e028c83.pdf

scihub/10.1007/978-88-470-5415-8.pdf

zlib/Medicine/Renata Cífková (auth.), Giuseppe Mancia (eds.)/Resistant Hypertension: Epidemiology, Pathophysiology, Diagnosis and Treatment_2146580.pdf

Mancia, Giuseppe

Springer Healthcare Italia Srl

Springer; Giuseppe Mancia

Springer London, Limited

publisher not identified

Springer-Verlag Italia

Place of publication not identified, 2013

Springer Nature, Milan, 2013

Milano, cop. 2013

Jul 24, 2013

Italy, Italy

uuuu

sm21658241

{"edition":"1","isbns":["8847054141","884705415X","9788847054141","9788847054158"],"last_page":195,"publisher":"Springer"}

Source title: Resistant Hypertension: Epidemiology, Pathophysiology, Diagnosis and Treatment

A growing number of people suffer from so-called resistant hypertension, that is to say, high blood pressure that does not respond to treatment. This disorder is of great current interest and importance for public health, being a common clinical problem faced by both primary care clinicians and specialists. Furthermore, as older age and obesity are among the strongest risk factors for uncontrolled hypertension, the incidence of resistant hypertension will likely increase as the population becomes more elderly and heavier. While the prognosis of resistant hypertension is unknown, cardiovascular risk is undoubtedly increased since patients often have a history of long-standing, severe hypertension complicated by multiple other cardiovascular risk factors. This volume, compiled by a panel of world-renowned experts, offers a comprehensive exploration of resistant hypertension, covering epidemiology, complex diagnostic aspects, and the therapeutic options currently available, with due attention to overall treatment strategies. New therapeutic agents and procedures, such as renal denervation and baroreceptor stimulation, are also described. In addition, the book addresses the economic aspects of resistant hypertension and the role of the different professional figures, from GPs to hypertension specialists, in dealing with it.
Erscheinungsdatum: 13.08.2013

La 4e de couverture indique :"A growing number of people suffer from so-called resistant hypertension, that is to say, high blood pressure that does not respond to treatment. This disorder is of great current interest and importance for public health, being a common clinical problem faced by both primary care clinicians and specialists. Furthermore, as older age and obesity are among the strongest risk factors for uncontrolled hypertension, the incidence of resistant hypertension will likely increase as the population becomes more elderly and heavier. While the prognosis of resistant hypertension is unknown, cardiovascular risk is undoubtedly increased since patients often have a history of long-standing, severe hypertension complicated by multiple other cardiovascular risk factors. This volume, compiled by a panel of world-renowned experts, offers a comprehensive exploration of resistant hypertension, covering epidemiology, complex diagnostic aspects, and the therapeutic options currently available, with due attention to overall treatment strategies. New therapeutic agents and procedures, such as renal denervation and baroreceptor stimulation, are also described. In addition, the book addresses the economic aspects of resistant hypertension and the role of the different professional figures, from GPs to hypertension specialists, in dealing with it."

Front Matter....Pages i-viii
Resistant Hypertension: Definition, Prevalence, and Cardiovascular Risk....Pages 1-8
Front Matter....Pages 9-9
Resistant Hypertension: Neurohumoral Aspects....Pages 11-21
Metabolic Alterations....Pages 23-37
Cardiac and Vascular Alterations in Resistant Hypertension....Pages 39-50
The Pathophysiology of the Kidney in Resistant Hypertension....Pages 51-56
Front Matter....Pages 57-57
False Versus True Resistant Hypertension....Pages 59-75
Causes of Resistant Hypertension....Pages 77-94
24-hour Ambulatory BP Monitoring and Home BP Measurements in Resistant Hypertension....Pages 95-105
Factors Predicting Blood Pressure Response to Treatment....Pages 107-113
Treatment of Resistant Hypertension. Which Additional Antihypertensive Drugs?....Pages 115-126
The Role of Renal Denervation....Pages 127-136
The Role of Carotid Baroreceptor Stimulation....Pages 137-144
Pathophysiology: Metabolic Alterations and Risk Factors....Pages 145-153
Follow-up of Patients with Resistant Hypertension....Pages 155-169
Resistant Hypertension: Cost-Benefit Considerations....Pages 171-180
Involvement of Health Professionals: From the General Practitioner to the Hypertension Specialist and the Hypertension Center....Pages 181-191
Back Matter....Pages 193-195

2013-08-01